View Archive »
About The Cover
Geminin localization in HME cells. Geminin localization in HME cells. Shown is the localization of geminin (green) and γ-tubulin (red) during in cytokinesis. See Blanchard et al.
|
|
Table of Contents
|
| Galectin1 as an oncotarget in gliomas and melanomas |
|
https://doi.org/10.18632/oncotarget.408
|
| 892-893 |
|
| Resistance to EGFR inhibitors: Molecular determinants and the enigma of head and neck cancer |
|
https://doi.org/10.18632/oncotarget.407
|
| 894-895 |
Reviews
|
| Metformin: Multifaceted protection against cancer |
|
https://doi.org/10.18632/oncotarget.387
|
| 896-917 |
|
| AHI1: a novel signaling protein and potential therapeutic target in human leukemia and brain disorders |
|
https://doi.org/10.18632/oncotarget.405
|
| 918-934 |
|
| Mitotic centromereassociated kinesin MCAK: a potential cancer drug target |
|
https://doi.org/10.18632/oncotarget.416
|
| 935-947 |
|
| Regulation of glucose metabolism by p53: Emerging new roles for the tumor suppressor |
|
https://doi.org/10.18632/oncotarget.389
|
| 948-957 |
Special Feature: Editorial
|
| Mechanism of Activation of AMPK and Upregulation of OGG1 by Rapamycin in Cancer Cells |
|
https://doi.org/10.18632/oncotarget.381
|
| 958-959 |
Brief Reports
|
| Pilot study of a pediatric metronomic 4drug regimen |
|
https://doi.org/10.18632/oncotarget.358
|
| 960-965 |
|
| MED12 exon 2 mutations are common in uterine leiomyomas from South African patients |
|
https://doi.org/10.18632/oncotarget.370
|
| 966-969 |
|
| CRIP1 expression is correlated with a favorable outcome and less metastases in osteosarcoma patients |
|
https://doi.org/10.18632/oncotarget.398
|
| 970-975 |
|
| Frizzled receptor 6 marks rare highly tumourigenic stemlike cells in mouse and human neuroblastomas |
|
https://doi.org/10.18632/oncotarget.410
|
| 976-983 |
Research Papers
|
| PARP inhibition sensitizes childhood high grade glioma medulloblastoma and ependymoma to radiation |
|
https://doi.org/10.18632/oncotarget.362
|
| 984-996 |
|
| Antitumoral activity of allosteric inhibitors of Protein kinase CK2 |
|
https://doi.org/10.18632/oncotarget.361
|
| 997-1010 |
|
| Geminin overexpression induces mammary tumors via suppressing cytokinesis |
|
https://doi.org/10.18632/oncotarget.363
|
| 1011-1027 |
|
| Cord blood stem cells revert glioma stem cell EMT by down regulating transcriptional activation of Sox2 and Twist1 |
|
https://doi.org/10.18632/oncotarget.367
|
| 1028-1042 |
|
| Putting the brakes on mammary tumorigenesis: Loss of STAT1 predisposes to intraepithelial neoplasias |
|
https://doi.org/10.18632/oncotarget.371
|
| 1043-1054 |
|
| A Novel Dual Signaling Axis for NSP 5a3a induced apoptosis in Head and Neck Carcinoma |
|
https://doi.org/10.18632/oncotarget.306
|
| 1055-1074 |
|
| Annexin A2 is a novel Cellular Redox Regulatory Protein involved in Tumorigenesis |
|
https://doi.org/10.18632/oncotarget.375
|
| 1075-1093 |
|
| DNAPKCS binding to p53 on the p21WAF1/CIP1 promoter blocks transcription resulting in cell death |
|
https://doi.org/10.18632/oncotarget.378
|
| 1094-1108 |
|
| Thyrocytespecific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumors |
|
https://doi.org/10.18632/oncotarget.380
|
| 1109-1126 |
|
| Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height |
|
https://doi.org/10.18632/oncotarget.385
|
| 1127-1133 |
|
| PIM kinase isoform specific regulation of MIG6 expression and EGFR signaling in prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.386
|
| 1134-1144 |
|
| TAp73alpha protects small cell lung carcinoma cells from caspase2 induced mitochondrial mediated apoptotic cell death |
|
https://doi.org/10.18632/oncotarget.391
|
| 1145-1154 |
|
| Phosphatase inhibitor sodium stibogluconate in combination with interferon IFN alpha 2b: phase I trials to identify pharmacodynamic and clinical effects |
|
https://doi.org/10.18632/oncotarget.563
|
| 1155-1164 |
|
| Overexpression of TWIST2 correlates with poor prognosis in Head and Neck Squamous Cell Carcinomas |
|
https://doi.org/10.18632/oncotarget.390
|
| 1165-1175 |
|
| Phospholipase PLA2G7 associated with aggressive prostate cancer promotes prostate cancer cell migration and invasion and is inhibited by statins |
|
https://doi.org/10.18632/oncotarget.397
|
| 1176-1190 |
|
| Genomewide analysis discloses reversal of the hypoxiainduced changes of gene expression in colon cancer cells by zinc supplementation |
|
https://doi.org/10.18632/oncotarget.395
|
| 1191-1202 |
|
| Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a proinvasive secretome |
|
https://doi.org/10.18632/oncotarget.382
|
| 1203-1217 |
|
| The suppression of FOXM1 and its targets in breast cancer xenograft tumors by siRNA |
|
https://doi.org/10.18632/oncotarget.359
|
| 1218-1226 |
|
| Characterization of the Human Folate Receptor Alpha Via Novel AntibodyBased Probes |
|
https://doi.org/10.18632/oncotarget.412
|
| 1227-1243 |
|
| A Modular Strategy to Prepare Multivalent Inhibitors of ProstateSpecific Membrane Antigen PSMA |
|
https://doi.org/10.18632/oncotarget.415
|
| 1244-1253 |
|
| Pooled shRNA screen for sensitizers to inhibition of the mitotic regulator pololike kinase PLK1 |
|
https://doi.org/10.18632/oncotarget.406
|
| 1254-1264 |
|
| Identification of a chrXq273 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients |
|
https://doi.org/10.18632/oncotarget.401
|
| 1265-1278 |
|
| Selenium is a modulator of circadian clock that protects mice from the toxicity of a chemotherapeutic drug via upregulation of the core clock protein BMAL1 |
|
https://doi.org/10.18632/oncotarget.411
|
| 1279-1290 |
|
| Epigenetic regulation of DeltaLike1 controls Notch1 activation in gastric cancer |
|
https://doi.org/10.18632/oncotarget.414
|
| 1291-1301 |
Research Perspectives
|
| Targeting Autophagy Addiction in Cancer |
|
https://doi.org/10.18632/oncotarget.384
|
| 1302-1306 |
|
| Finding cancer’s weakest link |
|
https://doi.org/10.18632/oncotarget.396
|
| 1307-1313 |
|
| Will PI3K pathway inhibitors be effective as single agents in patients with cancer |
|
https://doi.org/10.18632/oncotarget.409
|
| 1314-1321 |
|
| AMPK in BCRABL expressing leukemias Regulatory effects and therapeutic implications |
|
https://doi.org/10.18632/oncotarget.413
|
| 1322-1328 |
|
| Is human cytomegalovirus a target in cancer therapy |
|
https://doi.org/10.18632/oncotarget.383
|
| 1329-1338 |
|
| T cell but not tumor cellproduced TGFβ1 promotes the development of spontaneous mammary cancer |
|
https://doi.org/10.18632/oncotarget.403
|
| 1339-1351 |
|
| NCI’s provocative questions on cancer: some answers to ignite discussion |
|
https://doi.org/10.18632/oncotarget.432
|
| 1352-1367 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
